Latest Survival news
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Severe COVID-19 Elevated for Childhood Cancer Survivors
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum Related Articles
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
KRAS ctDNA Linked to Worse Overall Survival in Localized Pancreatic Cancer 
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Hematologic Cancer Survivors Face Higher Risk of Developing Cardiovascular Disease Monthly Specialist Briefings
Stay Connected
